Search for tag: "symptoms"

29 Media

02:06 Chronic Respiratory Diseases CRD in Primary Care… Chronic Respiratory Diseases CRD in Primary Care Settings	Chronic Respiratory Diseases CRD in Primary Care Settings MOOC TRAILER ocp trailer care diseases treatment workers settings diagnosis disease resource workforce access variation account context advice understanding role evidence experience studies symptoms From Mari-Nikol Panteva on March 18th, 2021 0 likes 0 plays 0 Licence Type Creative Commons - Attribution Share A Like Date Created March 18th, 2021
54:07 CP2 CNS4 Anxiolytics and Antidepressants Dr Phil… CP2 CNS4 Anxiolytics and Antidepressants Dr Phil Larkman	CP2 CNS4 Anxiolytics and Antidepressants Dr Phil Larkman Drugs use to treat anxiety and affective disorders drugs anxiety symptoms benzodiazepines depression disorders brain disorder monoamine action antidepressants effects hippocampus behaviour amygdala mechanisms mechanism stress symptomology oxidase From Philip Larkman on March 5th, 2021 0 likes 62 plays 0 Licence Type Creative Commons - Attribution
01:05:26 CP2 CNS2 Parkinson's disease Dr Phil Larkman CP2 CNS2 Parkinson's disease Dr Phil Larkman	CP2 CNS2 Parkinson's disease Dr Phil Larkman Pharmacology of Parkinson's disease l-dopa dopamine disease dopa neurons pathway brain parkinson ganglia basal motor symptoms output treatment receptors nuclei degeneration drug drugs phosphorylation pathophysiology From Philip Larkman on March 2nd, 2021 0 likes 17 plays 0 Licence Type Creative Commons - Attribution
20:13 Statistics in COVID-19: Katie Allison (COVID… Statistics in COVID-19: Katie Allison (COVID Public Health Directorate)	Statistics in COVID-19: Katie Allison (COVID Public Health Directorate) Katie Allison (COVID Public Health Directorate): COVID-19 Infection Survey (CIS) in Scotland. The CfS Research Day gathered together experts in the analysis of Covid-19 data to discuss current… statistics covid-19 scotland symptoms week bit uncertainty age sample percent antibodies questions households covid 18th proportion confidence intervals hand infection survey england From Belle Taylor on March 1st, 2021 0 likes 2 plays 0 Publisher Centre for Statistics Licence Type All rights reserved Language English Date Created March 1st, 2021
39:49 UK-APASI in Mathematical Sciences: Jasmina… UK-APASI in Mathematical Sciences: Jasmina Panovska-Griffiths (Lecture 4)	UK-APASI in Mathematical Sciences: Jasmina Panovska-Griffiths (Lecture 4) Subtitles will be added soon. Tuesday 23 February 2021 UK-APASI in Mathematical Sciences Jasmina Panovska-Griffiths - Statistical analysis to identify risks groups of COVID-19 and to explore… symptoms risk testing modelling flow regression analysis study pcr rt infection model wave austria tests yesterday variables characteristics trend care From Liam Holligan on February 23rd, 2021 0 likes 10 plays 0 Publisher Liam Holligan Licence Type All rights reserved Language English Date Created February 23rd, 2021
08:49 The burden of chronic respiratory diseases The burden of chronic respiratory diseases	The burden of chronic respiratory diseases The burden of chronic respiratory diseases for individuals their families and the community. chronic respiratory diseases disease asthma breathing symptoms breathlessness care air airways burden interventions settings resource dust pollution smoke exposure loss anxiety medicines lung From Geoffrey Fortescue on December 10th, 2020 0 likes 10 plays 0 Licence Type Creative Commons - Attribution Share A Like
47:23 Kaltura Capture recording - December 9th 2020,… Kaltura Capture recording - December 9th 2020, 2:02:28 pm	Kaltura Capture recording - December 9th 2020, 2:02:28 pm Introduction to Exercise Prescription for Rehabilitation Part 2 exercise prescription exercise rehabilitation rehabilitation exercise individual activity assessment participation heart programme condition symptoms rate intensity tests week individuals process specialist performance markers monitoring bit From Claire Fitzsimons on December 9th, 2020 0 likes 86 plays 0 Course Code SPRT10025 Publisher Claire Fitzsimons Licence Type Creative Commons - Attribution Language English Date Created December 9th, 2020
11:59 Pharmacology 3: Parkinson's Disease - Part 4… Pharmacology 3: Parkinson's Disease - Part 4 Dr Phil Larkman	Pharmacology 3: Parkinson's Disease - Part 4 Dr Phil Larkman Causes disease neurons parkinson phosphorylation aggregates cells stress dopamine pathophysiology cases death processes symptoms factors protein brain mptp cell levels degeneration From Philip Larkman on November 15th, 2020 0 likes 77 plays 0 Licence Type Creative Commons - Attribution
09:31 Pharmacology 3: Parkinson's Disease - Part 1… Pharmacology 3: Parkinson's Disease - Part 1 Dr Phil Larkman	Pharmacology 3: Parkinson's Disease - Part 1 Dr Phil Larkman Symptoms and pathophysiology motor neurons disease symptoms patient dopamine ganglia basal signals regions patients parkinson thalamus control degeneration disorder pathway nigra substantia nucleus From Philip Larkman on November 15th, 2020 0 likes 81 plays 0 Licence Type Creative Commons - Attribution
01:36 Pharmacology 3: Parkinson's Disease -… Pharmacology 3: Parkinson's Disease - Introduction Dr Phil Larkman	Pharmacology 3: Parkinson's Disease - Introduction Dr Phil Larkman Introduction and learning outcomes disease pathophysiology disorder brain parkinson function symptomology parts series treatments future definition drugs treatment approaches principles ganglia basal dysfunction symptoms From Philip Larkman on November 15th, 2020 0 likes 69 plays 0 Licence Type Creative Commons - Attribution
12:18 Pharmacology 3: Parkinson's Disease - Part 3… Pharmacology 3: Parkinson's Disease - Part 3 Dr Phil Larkman	Pharmacology 3: Parkinson's Disease - Part 3 Dr Phil Larkman Drug treatment dopa dopamine treatment brain disease parkinson levels patient effect drug decarboxylase drugs oxidase conversion ganglia basal methyltransferase monoamine symptoms receptors From Philip Larkman on November 15th, 2020 0 likes 80 plays 0 Licence Type Creative Commons - Attribution
15:30 Pharmacology 3: Antidepressant Drugs - Part 2 Dr… Pharmacology 3: Antidepressant Drugs - Part 2 Dr Phil Larkman	Pharmacology 3: Antidepressant Drugs - Part 2 Dr Phil Larkman Theory of Depression drugs monoamine depression symptoms levels antidepressants cortisol noradrenalin theory release evidence actions serotonin patients pathway hippocampus neurons neurotransmitters brain disorders From Philip Larkman on November 14th, 2020 0 likes 87 plays 0 Licence Type Creative Commons - Attribution
06:21 Pharmacology 3: Antidepressant Drugs - Part 1 Dr… Pharmacology 3: Antidepressant Drugs - Part 1 Dr Phil Larkman	Pharmacology 3: Antidepressant Drugs - Part 1 Dr Phil Larkman Symptoms and pathophysiology symptoms symptomology brain disorders behaviour drugs function dysfunction control parts oscillation mania depression syndrome drug mechanism action mechanisms investigations pleasure From Philip Larkman on November 14th, 2020 0 likes 76 plays 0 Licence Type Creative Commons - Attribution
03:30 Pharmacology 3: Antidepressant Drugs -… Pharmacology 3: Antidepressant Drugs - Introduction Dr Phil Larkman	Pharmacology 3: Antidepressant Drugs - Introduction Dr Phil Larkman Introduction and learning outcomes disorders risk symptoms behaviour drug factors disorder depression pharmacokinetics pathophysiology action dysfunction brain understanding knowledge disease genes gene prevalence expression From Philip Larkman on November 14th, 2020 0 likes 84 plays 0 Licence Type Creative Commons - Attribution
06:01 Pharmacology 3: Anxiolytic Drugs - Part 1 Dr Phil… Pharmacology 3: Anxiolytic Drugs - Part 1 Dr Phil Larkman	Pharmacology 3: Anxiolytic Drugs - Part 1 Dr Phil Larkman Symptoms and pathophysiology anxiety disorder amygdala symptoms disorders activation activity axis release hippocampus stress control drugs cortisol hpa crf response fear pathophysiology cortex From Philip Larkman on November 12th, 2020 0 likes 101 plays 0 Licence Type Creative Commons - Attribution
02:36 Pharmacology 3: Anxiolytic Drugs - Introduction… Pharmacology 3: Anxiolytic Drugs - Introduction Dr Phil Larkman	Pharmacology 3: Anxiolytic Drugs - Introduction Dr Phil Larkman Introduction and learning outcomes anxiety disorder behaviour symptoms drugs benzodiazepines pharmacokinetics pathophysiology characteristics understanding exaggeration neurosis control outcomes approach properties modifications class lack disorders From Philip Larkman on November 12th, 2020 0 likes 88 plays 0 Licence Type Creative Commons - Attribution

the university of edinburgh

University affiliations

The University of Edinburgh is a charitable body, registered in Scotland, with registration number SC005336, VAT Registration Number GB 592 9507 00, and is acknowledged by the UK authorities as a “Recognised body” which has been granted degree awarding powers.

Unless explicitly stated otherwise, all material is copyright © The University of Edinburgh 2019. Course specific materials are created by University of Edinburgh staff for you to use in your studies. You should not share, publish or sell these outside the University